Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease.

Kramer, H H; Sommer, M; Rammos, S; Krogmann, O

Kramer, H H; Sommer, M; Rammos, S; Krogmann, O.

Affiliation

Kramer HH; Department of Paediatric Cardiology, Children's Hospital, Heinrich-Heine-University, Düsseldorf, Germany.

Eur J Pediatr ; 154(9): 700-7, 1995 Sep.

Article in En | MEDLINE | ID: mdl-8582419

Subject(s)

Alprostadil/administration & dosage; Heart Defects, Congenital/drug therapy; Vasodilator Agents/administration & dosage; Aortic Coarctation/drug therapy; Female; Heart Defects, Congenital/physiopathology; Humans; Infant, Newborn; Male; Respiration; Retrospective Studies; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vasodilator Agents / Alprostadil / Heart Defects, Congenital Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Newborn Language: En Journal: Eur J Pediatr Year: 1995 Document type: Article Affiliation country: Germany Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links